• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿崩症的现代治疗方法。

Modern approach in treatment of diabetes insipidus.

作者信息

Kapić Elvedina, Becić Fahir, Todić Maida

机构信息

Institute for Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Sarajevo, Cekalusa 90, 71 000 Sarajevo, Bosnia and Herzegovina.

出版信息

Bosn J Basic Med Sci. 2005 May;5(2):38-42. doi: 10.17305/bjbms.2005.3282.

DOI:10.17305/bjbms.2005.3282
PMID:16053453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7214070/
Abstract

In this paper we have reviewed the position of desmopressin in the treatment of diabetes insipidus. Desmopressin is a synthetic analog of vasopressin, with more pronounced antidiuretic effect. It is treatment of choice in substitution therapy of diabetes insipidus. Its application before sleeping time can reduce nocturnal enuresis, so it has a place in the treatment of enuresis nocturna. Antidiuretic effect of desmopressin is the result of agonistic effect on V2 receptors in the renal tubules. The efficacy and safety of desmopressin in mentioned indications was confirmed in clinical studies.

摘要

在本文中,我们回顾了去氨加压素在治疗尿崩症中的地位。去氨加压素是血管加压素的合成类似物,具有更显著的抗利尿作用。它是尿崩症替代治疗的首选药物。睡前使用可减少夜间遗尿,因此在治疗夜间遗尿方面也有一席之地。去氨加压素的抗利尿作用是对肾小管V2受体激动作用的结果。临床研究证实了去氨加压素在上述适应症中的疗效和安全性。

相似文献

1
Modern approach in treatment of diabetes insipidus.尿崩症的现代治疗方法。
Bosn J Basic Med Sci. 2005 May;5(2):38-42. doi: 10.17305/bjbms.2005.3282.
2
Desmopressin (DDAVP) for enuresis, diabetes insipidus, and..去氨加压素(DDAVP)用于治疗遗尿症、尿崩症以及……
Urol Nurs. 2004 Dec;24(6):520-3.
3
Clinical experience with desmopressin: efficacy and safety in central diabetes insipidus and other conditions.去氨加压素的临床经验:在中枢性尿崩症及其他病症中的疗效与安全性
J Pediatr. 1989 Apr;114(4 Pt 2):711-8. doi: 10.1016/s0022-3476(89)80886-8.
4
Desmopressin for nocturnal enuresis in nephrogenic diabetes insipidus.去氨加压素用于治疗肾性尿崩症的夜间遗尿症。
Lancet. 2002 Feb 9;359(9305):495-7. doi: 10.1016/S0140-6736(02)07667-5.
5
Desmopressin for diabetes insipidus, hemostatic disorders and enuresis.去氨加压素用于治疗尿崩症、止血障碍和遗尿症。
Am Fam Physician. 1990 Oct;42(4):1051-7.
6
[Diabetes insipidus: approaches to desmopressin substitution therapy].
Klin Med (Mosk). 2011;89(4):30-3.
7
[The treatment of diabetes insipidus in 1999].
Rev Med Interne. 1999 Aug;20 Suppl 3:399s-400s.
8
[Water intoxication following desmopressin overdose].[去氨加压素过量导致水中毒]
Harefuah. 1997 Apr 1;132(7):465-7, 527, 526.
9
Three cases of diabetes insipidus complicating pregnancy.三例妊娠合并尿崩症的病例。
J Matern Fetal Neonatal Med. 2004 Jul;16(1):61-3. doi: 10.1080/14767050410001728944.
10
Nocturnal enuresis in patients with nephrogenic diabetes insipidus.
Lancet. 2002 Aug 24;360(9333):642; author reply 642-3. doi: 10.1016/S0140-6736(02)09791-X.

引用本文的文献

1
dDAVP Downregulates the AQP3-Mediated Glycerol Transport V1aR in Human Colon HCT8 Cells.去氨加压素下调人结肠HCT8细胞中由水通道蛋白3介导的甘油转运体V1aR。
Front Cell Dev Biol. 2022 Jul 8;10:919438. doi: 10.3389/fcell.2022.919438. eCollection 2022.
2
3T renal (23)Na-MRI: effects of desmopressin in patients with central diabetes insipidus.3T 肾脏(23)Na-MRI:去氨加压素对中枢性尿崩症患者的影响。
MAGMA. 2014 Feb;27(1):47-52. doi: 10.1007/s10334-013-0377-4. Epub 2013 Apr 6.

本文引用的文献

1
Desmopressin for nocturnal enuresis in nephrogenic diabetes insipidus.去氨加压素用于治疗肾性尿崩症的夜间遗尿症。
Lancet. 2002 Feb 9;359(9305):495-7. doi: 10.1016/S0140-6736(02)07667-5.
2
A clinical feature of hyperlipidemia in patients with central diabetes insipidus.
Endocr J. 2000 Oct;47(5):557-62. doi: 10.1507/endocrj.47.557.
3
Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patients.醋酸去氨加压素鼻内给药治疗甲型血友病和血管性血友病期间的不良事件:一例病例报告及40例患者的综述
Haemophilia. 2000 Jan;6(1):11-4. doi: 10.1046/j.1365-2516.2000.00367.x.
4
Desmopressin resistant enuresis: pathogenetic and therapeutic considerations.
J Urol. 1999 Dec;162(6):2136-40. doi: 10.1016/S0022-5347(05)68142-6.
5
Convulsions and respiratory arrest in association with desmopressin administration for the treatment of a bleeding tonsil in a child with borderline haemophilia.在一名患有边缘性血友病的儿童中,使用去氨加压素治疗扁桃体出血时出现惊厥和呼吸骤停。
Acta Anaesthesiol Scand. 1999 Sep;43(8):870-3. doi: 10.1034/j.1399-6576.1999.430817.x.
6
Low-dose desmopressin in the treatment of nocturnal urinary incontinence in the exstrophy-epispadias complex.
BJU Int. 1999 Aug;84(3):329-34. doi: 10.1046/j.1464-410x.1999.00195.x.
7
Hyponatraemic convulsion secondary to desmopressin treatment for primary enuresis.原发性遗尿症采用去氨加压素治疗继发低钠血症惊厥。
J Accid Emerg Med. 1999 May;16(3):229-30. doi: 10.1136/emj.16.3.229.
8
Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study.
BJU Int. 1999 Apr;83(6):591-5. doi: 10.1046/j.1464-410x.1999.00012.x.
9
The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis.去氨加压素的疗效与持续性夜间遗尿症患者尿量的昼夜节律有关。
Clin Endocrinol (Oxf). 1998 Dec;49(6):793-801. doi: 10.1046/j.1365-2265.1998.00587.x.
10
Desmopressin for the treatment of nocturnal polyuria in the elderly: a dose titration study.
Br J Urol. 1998 Nov;82(5):642-6. doi: 10.1046/j.1464-410x.1998.00849.x.